Acquired immunodeficiency syndrome (AIDS) dementia complex, now more frequently termed HIV- associated dementia (HAD), is the most severe CNS complication of HIV infection [1] [2]. Despite the introduction of antiretroviral therapy (ART) in recent decades and marked success in therapy that led to a reduction in CNS complications, the increased life expectancy of patients suffering from this viral infection has actually increased the rate of HAD according to certain reports [1] [3] [4]. Failure to comply with therapy is the single most important risk factor, and the clinical presentation is distinguished by the onset of subcortical dementia, due to the fact that aphasia, apraxia and other signs of cortical damage are absent [5]. The clinical hallmarks of AIDS dementia complex is a slowly progressive deceleration in, motor, cognitive and behavioral functions over the course of weeks or months [4] [6] [7]. In the initial stages, only minor symptoms, such as difficulties performing complex tasks and memory loss, may be observed [5]. Over time, however, more pronounced signs include psychomotor decline, mood changes (depression, apathy, but also mania), anxiety (and even psychosis), reduced capacity to process information, as well as more severe memory, but also language and attention deficits, which are rather common and can significantly impair daily life [3] [4] [5] [8]. Olfactory senses are also reduced [3], and notable neurologic symptoms can be paraparesis, spasticity of the lower extremities, less pronounced reflexes, postural tremor, ataxia and gait disturbances [5] [9].

The diagnosis of AIDS dementia complex requires a comprehensive workup, starting with a meticulous patient history that will confirm the presence of an HIV infection and exclude other potential causes of such symptoms (for eg. recent substance abuse, Alzheimer disease, Parkinson's disease, CNS infections or other disorders) [4] [8]. In addition to the patient interview, the onset and course of symptoms should be assessed with the family of the patient, as they can provide vital information. Compliance with therapy and possible coinfections must be noted as well, after which a thorough physical examination, considered as the essential component of the workup, is performed. The diagnosis of AIDS dementia complex primarily rests on findings obtained during a physical exam, and a full physical and neurologic exam followed by a complete cognitive assessment are imperative [1] [2] [4] [6]. The HIV dementia scale and other proposed criteria roughly divide patients suffering from HIV-associated dementia (HAD) into 3 categories: HAD with motor symptoms, HAD with either psychosocial or behavioral symptoms and HAD with both motor and behavioral/psychosocial signs [5] [6] [9]. Regardless of the stage and severity of symptoms, determination of CD4+ T-cell counts is recommended in all HIV+ patients who exhibit such complaints, and HAD is often diagnosed in individuals with a CD4+ T-cell count of < 200/mm3 [8]. A polymerase chain reaction (PCR) testing to detect the viral load of HIV RNA in serum and cerebrospinal fluid (obtained through a lumbar puncture) must be carried out [5] [9]. Imaging studies are also an important part of the diagnosis of AIDS dementia complex [9]. Computed tomography (CT), but more commonly magnetic resonance imaging (MRI), can show atrophy of the subcortical, but also cortical structures in the advanced stages of the disease [4] [5].

The primary treatment for AIDS Dementia Complex is antiretroviral therapy (ART), which helps to control the HIV infection and reduce viral load. This can lead to an improvement in symptoms or slow the progression of the disease. In addition to ART, supportive therapies such as physical therapy, occupational therapy, and cognitive rehabilitation may be beneficial. Medications to manage specific symptoms, such as antidepressants or antipsychotics, may also be prescribed.

The prognosis for individuals with AIDS Dementia Complex has improved significantly with the advent of effective antiretroviral therapy. Many patients experience stabilization or improvement in symptoms with appropriate treatment. However, the prognosis can vary depending on the stage of HIV infection, the patient's overall health, and how early the condition is diagnosed and treated.

AIDS Dementia Complex is caused by the direct effects of the HIV virus on the central nervous system. The virus can cross the blood-brain barrier and infect brain cells, leading to inflammation and damage. This process disrupts normal brain function, resulting in the cognitive, motor, and behavioral symptoms associated with ADC.

The incidence of AIDS Dementia Complex has decreased significantly in regions where antiretroviral therapy is widely available. However, it remains a concern in areas with limited access to HIV treatment. ADC is more common in individuals with advanced HIV infection and low CD4 counts, which are indicators of a weakened immune system.

The pathophysiology of AIDS Dementia Complex involves the infiltration of HIV-infected cells into the brain. This leads to the release of inflammatory molecules and neurotoxins that damage neurons and disrupt neural networks. The resulting inflammation and neuronal injury are responsible for the cognitive and motor deficits observed in ADC.

Preventing AIDS Dementia Complex primarily involves effective management of HIV infection. This includes early diagnosis and initiation of antiretroviral therapy to maintain a low viral load and preserve immune function. Regular monitoring and adherence to treatment are crucial to prevent the progression of HIV and the development of neurological complications.

AIDS Dementia Complex is a serious neurological condition associated with advanced HIV infection. It presents with cognitive, motor, and behavioral symptoms and requires a comprehensive diagnostic workup. Treatment with antiretroviral therapy can improve outcomes, and early intervention is key to preventing progression. Understanding the etiology, pathophysiology, and prevention strategies is essential for managing this condition effectively.

If you or someone you know is living with HIV and experiencing symptoms such as memory loss, difficulty concentrating, or changes in behavior, it is important to seek medical evaluation. Early diagnosis and treatment can help manage symptoms and improve quality of life. Regular follow-up with healthcare providers and adherence to prescribed treatments are essential components of managing HIV and preventing complications like AIDS Dementia Complex.

1. Kaul M. HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches. Curr Opin Neurol. 2009;22(3):315-320.
2. Ghafouri M, Amini S, Khalili K, Sawaya BE. HIV-1 associated dementia: symptoms and causes. Retrovirology. 2006;3:28.
3. Lindl KA, Marks DR, Kolson DL, Jordan-Sciutto KL. HIV-Associated Neurocognitive Disorder: Pathogenesis and Therapeutic Opportunities. J Neuroimmune Pharmacol. 2010;5(3):294-309.
4. Alfahad TB, Nath A. Update on HIV-associated Neurocognitive Disorders. Curr Neurol Neurosci Rep 2013;13(10):387.
5. Porter RS, Kaplan JL. Merck Manual of Diagnosis and Therapy. 19th Edition. Merck Sharp & Dohme Corp. Whitehouse Station, N.J; 2011.
6. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789-1799.
7. Zhou L, Saksena NK. HIV Associated Neurocognitive Disorders. Infect Dis Rep. 2013;5(1):e8. Mandell GL, Bennett JE, Dolin R.
8. Watkins CC, Treisman GJ. Cognitive impairment in patients with AIDS – prevalence and severity. HIV AIDS (Auckl). 2015;7:35-47.
9. Mandel, Douglas and Bennett's Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, Pennsylvania: Churchill Livingstone; 2015.